EPIPODOPHYLLIN DERIVATIVE (VP 16-213) IN MALIGNANT TERATOMAS AND CHORIOCARCINOMAS

Publisher Website

9 July 1977

journal article
other
Published by Elsevier in The Lancet

Vol. 310 (8028), 87
https://doi.org/10.1016/s0140-6736(77)90088-5

Abstract

No abstract available

This publication has 4 references indexed in Scilit:

SURVIVAL AFTER CARDIAC ARREST IN HOSPITAL
The Lancet, 1977
A clinical trial of the oral form of 4′-demethyl-epipodophyllotoxin-β-D ethylidene glucoside (NSC 141540) VP 16–213
Cancer, 1975
Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas
Cancer, 1974
Experience with 4′-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosis
European Journal of Cancer (1965), 1974

Cited by 46 articles